Full-Time

Business Intelligence Lead

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Senior, Expert

Norwood, MA, USA

This position is site-based, requiring full-time presence at Moderna’s site.

Category
Computational Biology
Public Health
Biology & Biotech
Required Skills
Python
R
SQL
Data Analysis
Requirements
  • Bachelor’s degree in a STEM field.
  • 10+ years of experience in digital strategy, data integration, or a related role within the pharmaceutical or biotechnology industry (7+ years with a Master's degree).
  • Proven track record of implementing digital tools and improving data processes.
  • Strong project management and leadership skills.
  • Knowledge of CSV requirements.
  • Excellent communication and collaboration abilities.
  • Knowledge of SQL, cloud computing, Python or R programming.
Responsibilities
  • Collaborate with Digital and DS Network leadership to align digital and data initiatives with overall business strategy.
  • Lead the development and implementation of data strategy for the Drug Substance Network, ensuring effective data governance and utilization.
  • Lead the assessment and implementation of digital tools and technologies to enhance data tracking, entry, and integration.
  • Partner with the Digital organization to collaborate with internal and external stakeholders, including CMOs, to identify digital improvement opportunities.
  • Develop and manage project plans, ensuring timely delivery of improvements in alignment with business goals.
  • Identify and integrate advanced digital tools and technologies to enhance operational efficiency and data utilization.
  • Optimize data management practices, including data collection, storage, analysis, and reporting.
  • Provide training and support to team members on new digital tools and processes.
  • Monitor and report on the effectiveness of digital initiatives that impact the Drug Substance Network and recommend improvements.
  • Ensure compliance with regulatory and data security requirements.
  • Foster a culture of digital innovation and data-driven decision-making within the organization.
  • Follow all relevant GMP and GLP regulations, guidelines, and company policies to ensure compliance with regulatory and internal requirements.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

54%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?